SCHEMBL7529181

SCHEMBL7529181

CC(C)CC(C(=O)c1nc(C(=O)NCc2cccc3ccccc23)co1)N(C(=O)O)C(=O)NCCCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.40
KMT2A Q03164 2/20 0.39
SIGMAR1 Q99720 1/20 0.38
MTNR1A P48039 2/20 0.38
MMP8 P22894 1/20 0.38
FAAH O00519 1/20 0.38
MTNR1B P49286 1/20 0.38
ANPEP P15144 1/20 0.38
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TBXA2R P21731 1/20 0.36
PSMB5 P28074 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
DAGLA Q9Y4D2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7529166 0.78 KMT2A (0.42) KMT2AANPEPCYP2C9TBXA2RPSMB5
SCHEMBL6463671 0.73 REN (0.47) ANPEPCYP2C9CYP2C19
SCHEMBL7529175 0.72 PSMB5 (0.42) KMT2AANPEPCYP2C9TBXA2RPSMB5
SCHEMBL6063863 0.70 NFKB1 (0.41) MMP8ANPEPPSMB5
SCHEMBL6477967 0.70 MMP3 (0.44) KMT2AMMP8ANPEPCYP2D6CYP2C9
SCHEMBL6063167 0.67 CTSL (0.51)
SCHEMBL6063868 0.64 PSMB5 (0.44) MMP8ANPEPCYP2D6CYP2C19PSMB5
SCHEMBL7558531 0.63 DAGLA (0.39) KMT2AFAAHCYP2D6CYP2C9CYP2C19
SCHEMBL6467199 0.62 DAGLA (0.41) EPHX2TBXA2RDAGLA
SCHEMBL17749487 0.62 CHRNB2 (0.51) KMT2AMTNR1ACYP2C9HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161422-A1 AMINE DERIVATIVES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-12 EP disclosed
WO-2000055144-A1 AMINE DERIVATIVES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed